No Data
Does Shijiazhuang Yiling Pharmaceutical (SZSE:002603) Have A Healthy Balance Sheet?
Shijiazhuang Yiling Pharmaceutical (002603.SZ): The clinical trial registration application for the Traditional Chinese Medicine new drug "Lianhua Yuping Granules" has been approved.
Shijiazhuang Yiling Pharmaceutical (002603.SZ) announced that its wholly-owned subsidiary Peking Yiling Pharmaceutical Co., Ltd. ("Peking...
Yiling Pharmaceutical Unit Gets Nod to Market Simvastatin Tablets in US
Shenzhen Stock Exchange: Adjustment of the sample stocks for the Shenzhen component index, Chinext price index, and szse 100 price index.
On December 2, the Shenzhen Stock Exchange announced that according to the index compilation rules, the Shenzhen Stock Exchange and Shenzhen Securities Information Co., Ltd. decided to implement periodic adjustments to the Shenzhen Component Index, chinext price index, szse 100 price index, and other indexes on December 16, 2024.
Shijiazhuang Yiling Pharmaceutical (002603.SZ): Simvastatin tablets obtain the approval number from the FDA in the usa.
Shijiazhuang Yiling Pharmaceutical (002603.SZ) issued an announcement. Recently, the company received a notification from the US Food and Drug Administration (FDA)...
Shijiazhuang Yiling Pharmaceutical's Tongluo Mingmu Capsules Added to National Medical Insurance Catalog
Benign Growth For Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SZSE:002603) Underpins Its Share Price
No Data
